Literature DB >> 22090125

A role for the internal repeat of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen in the persistence of an episomal viral genome.

Khaled R Alkharsah1, Thomas F Schulz.   

Abstract

The latent nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus (KSHV) is required for the replication and partitioning of latent viral genomes. It contains an extended internal repeat (IR) region whose function is only incompletely understood. We constructed KSHV genomes lacking either LANA (KSHV-ΔLANA) or the IR region of LANA (KSHV-LANAΔ329-931). Although still capable of replicating a plasmid containing a latent origin of replication, LANAΔ329-931 does not support the establishment of stable cell lines containing a KSHV genome. These findings suggest a role for the LANA IR in KSHV episomal maintenance without its being required for replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090125      PMCID: PMC3264353          DOI: 10.1128/JVI.06029-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication.

Authors:  Alexander C Garber; Jianhong Hu; Rolf Renne
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

2.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Mutagenesis of herpesvirus BACs by allele replacement.

Authors:  Eva-Maria Borst; György Pósfai; Frank Pogoda; Martin Messerle
Journal:  Methods Mol Biol       Date:  2004

4.  The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter.

Authors:  Hong Li; Takashi Komatsu; Bruce J Dezube; Kenneth M Kaye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.

Authors:  C Rivas; A E Thlick; C Parravicini; P S Moore; Y Chang
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence.

Authors:  Erika De León Vázquez; Kenneth M Kaye
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.

Authors:  Fu-Chun Zhou; Yan-Jin Zhang; Jian-Hong Deng; Xin-Ping Wang; Hong-Yi Pan; Evelyn Hettler; Shou-Jiang Gao
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

Authors:  Michael Lagunoff; Jill Bechtel; Eleni Venetsanakos; Anne-Marie Roy; Nancy Abbey; Brian Herndier; Martin McMahon; Don Ganem
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.

Authors:  Harinivas H Krishnan; Pramod P Naranatt; Marilyn S Smith; Ling Zeng; Clark Bloomer; Bala Chandran
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Identification of a virus trans-acting regulatory element on the latent DNA replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Chunghun Lim; Taegun Seo; Jun Jung; Joonho Choe
Journal:  J Gen Virol       Date:  2004-04       Impact factor: 3.891

View more
  9 in total

1.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

2.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 3.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.

Authors:  Magdalena Weidner-Glunde; Giuseppe Mariggiò; Thomas F Schulz
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

4.  A short sequence immediately upstream of the internal repeat elements is critical for KSHV LANA mediated DNA replication and impacts episome persistence.

Authors:  Erika De León Vázquez; Franceline Juillard; Bernard Rosner; Kenneth M Kaye
Journal:  Virology       Date:  2013-11-12       Impact factor: 3.616

5.  Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation.

Authors:  Tuna Toptan; Lidia Fonseca; Hyun Jin Kwun; Yuan Chang; Patrick S Moore
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 6.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

Review 7.  Kaposi's Sarcoma Herpesvirus Genome Persistence.

Authors:  Franceline Juillard; Min Tan; Shijun Li; Kenneth M Kaye
Journal:  Front Microbiol       Date:  2016-08-12       Impact factor: 5.640

Review 8.  Kaposi sarcoma herpesvirus pathogenesis.

Authors:  Giuseppe Mariggiò; Sandra Koch; Thomas F Schulz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

9.  Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.

Authors:  Giuseppe Mariggiò; Sandra Koch; Guigen Zhang; Magdalena Weidner-Glunde; Jessica Rückert; Semra Kati; Susann Santag; Thomas F Schulz
Journal:  PLoS Pathog       Date:  2017-04-21       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.